Founded in 1992, French pharmaceutical laboratory EFFIK has dedicated its 30-year history to providing medical solutions tailored to the needs of women at every stage of their lives. From the outset, the laboratory's objective has been clear: to improve patient care by developing innovative gynecological products that are safe and comply with the strictest pharmaceutical industry standards.
EFFIK is much more than a company; it is a trusted partner for healthcare professionals. Thanks to a human-scale organization and highly specialized teams in Research and Development (R&D) and Quality Assurance, the laboratory has positioned itself as a key player in women's health in France and Europe. With solutions adapted to issues such as contraception, menopause and pregnancy supplementation, EFFIK meets the specific needs of millions of women, day after day.
Since its creation, EFFIK has evolved to become an undisputed leader in gynecology, an essential but often under-represented field. This positioning is based on close, ongoing collaboration with gynecologists, midwives, pharmacists and other healthcare professionals. Thanks to these partnerships, EFFIK is able to develop products that meet exacting requirements in terms of both performance and safety.
Women's health evolves with the times, and EFFIK is fully aware of this. Whether it's to support women in their contraceptive journey, their desire for pregnancy or the challenges of menopause, the laboratory has innovated and adapted to the changing needs of its patients. Each product is designed to provide a targeted solution, while improving the quality of daily life.
At EFFIK, innovation and excellence are more than just objectives: they are fundamental values that guide every decision. The company's vocation is to meet medical and human challenges while remaining true to its irreproachable ethics. From the outset, EFFIK has been committed to responsible entrepreneurship, respecting regulations and adopting a sustainable development approach.
EFFIK also valuesactive listening to the needs of women and healthcare professionals. This collaborative approach enables us to create solutions perfectly aligned with patient expectations, while ensuring continuous improvement of existing products. By choosing EFFIK, women benefit not only from cutting-edge medical expertise, but also from sincere, caring support.
In 2016, the laboratory made a significant shift by broadening its scope to include neurology and rare diseases. This expansion marks a new stage in the history of EFFIK, which is now committed to patients suffering from complex pathologies such as Amyotrophic Lateral Sclerosis (ALS ) and Duchenne muscular dystrophy. Although rare, these diseases have a major impact on the quality of life of patients and their families, and EFFIK is doing its utmost to develop innovative and accessible treatments.
The laboratory has set up a specialized team dedicated to these pathologies, and works closely with associations and healthcare professionals to provide concrete support at every stage of the care process. Thanks to its R&D advances, EFFIK continues to push back the boundaries of medicine in these fields, while remaining true to its initial ambition: to improve the lives of patients, whatever their condition.
EFFIK 's commitment is not limited to pharmaceutical research. The laboratory actively collaborates with recognized associations such asARSLA (Association pour la Recherche sur la Sclérose Latérale Amyotrophique) and theNational Spina Bifida Association. These partnerships aim to raise patient awareness and improve prevention of serious pathologies, while supporting the families affected.
Through concrete actions, such as training programs and solidarity initiatives (e.g. the Run for Heroes), EFFIK demonstrates its deep commitment to the communities it serves. These efforts reflect a simple yet powerful philosophy: every action undertaken by the laboratory is geared towards the well-being of patients and their loved ones.
At the heart of its mission, EFFIK remains resolutely forward-looking. The laboratory continues to develop innovative solutions while reinforcing its commitments to transparency, sustainable development andethics. As a responsible player, EFFIK aspires to become a global reference in the fields of gynecology and rare diseases, based on strong values and recognized expertise.
With such a commitment to innovation and health, EFFIK is much more than just a supplier of pharmaceutical products. It is a trusted partner, committed to improving the lives of women and patients around the world.
EFFIK offers a complete range of products, designed to meet the varied needs of patients and healthcare professionals. Each solution is the fruit of in-depth research, guaranteeing effectiveness and safety.
